Vaxart
Vaxart is a clinical-stage biotechnology company developing oral vaccines for infectious diseases.
Rate
About
Vaxart is a biotechnology company focused on developing oral vaccines for a range of infectious diseases, including COVID-19, influenza, and norovirus. Their proprietary oral tablet vaccine platform aims to provide a more convenient and accessible alternative to traditional injectable vaccines.
Technology stack
detected 2026-06-20Est. monthly stack spend~$810/mo
CDN
Cloudflare
Email
Barracuda
gateway-fronted
Stack
WordPress
SEO
Yoast SEO
Video
YouTube
Comments
No comments yet. Be the first to share your take.
Frequently asked
What does Vaxart do?
Vaxart is a biotechnology company focused on developing oral vaccines for a range of infectious diseases, including COVID-19, influenza, and norovirus. Their proprietary oral tablet vaccine platform aims to provide a more convenient and accessible alternative to traditional injectable vaccines.
Where is Vaxart headquartered?
Vaxart is headquartered in South San Francisco, United States.
When was Vaxart founded?
Vaxart was founded in 1998.
What industry does Vaxart operate in?
Vaxart operates in Biotech, MedTech, HealthTech, Vaccines, Drug Discovery, Clinical Trials.
How many employees does Vaxart have?
Vaxart has approximately 108 people on record.